Is BioMarin Pharmaceutical Inc. (BMRN) a Buy, Sell, or Hold?
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$58.64 USD
-$0.56 (-0.95%)
- Volume
- 1.39M
- Average Volume
- 2.06M
- Market Capitalization
- $11.33B
- P/E Ratio
- 41.89
- Dividend Yield
- 0.00%
- Price Target
- $84.00
- Year High
- $66.28
- Year Low
- $49.26
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.81
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
-30.2% DOWNSIDE
$84.00 Price Target
UPSIDE/DOWNSIDE HIGH
-51.1% DOWNSIDE
$120.00 Price Target High
UPSIDE/DOWNSIDE LOW
17.3% UPSIDE
$50.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Luca Issi | $62 | $58.79 | 2026-07-07 07:28 AM | 5.5% |
| Tudor Pickering | William Pickering | $82 | $55.46 | 2026-05-05 06:44 AM | 47.9% |
| Morgan Stanley | Sean Laaman | $120 | $53.18 | 2026-04-27 06:16 AM | 125.6% |
| Jefferies | Akash Tewari | $103 | $59.8588 | 2026-03-12 09:26 AM | 72.1% |
| Barclays | Eliana Merle | $105 | $59.74 | 2026-03-03 06:12 AM | 75.8% |